Method of recombinant macromolecular production
AssigneeDa Yu Enterprises, L.L.C.
InventorDonald O'Keefe
Life of this patent
Estimating the term…
Loading patent…
AssigneeDa Yu Enterprises, L.L.C.
InventorDonald O'Keefe
Estimating the term…
Methods for in situ drug screening are provided which involve culturing a host cell containing two nucleic acid sequences, the first nucleic acid sequence encoding a membrane-permeabilizing agent and the second nucleic acid sequence encoding a desired macromolecule under the operative control of an inducible promoter, to a selected cell density to produce a macromolecule. Thereafter the host cells are exposed to an environmental condition that induces the agent to disrupt the integrity of the cell membrane without complete lysis of the cell membrane, thereby allowing transport through the membrane of small molecular weight compounds. These resulting host cells are provided with a nutrient cocktail containing components that can transport through the disrupted cell membrane, e.g., an inducing agent that induces the tightly regulated promoter and metabolic requirements that permit expression of the macromolecule. Bacterial host cells that can be used in these methods are also provided.
A method for in situ drug screening comprising:
A method for in situ drug screening comprising:
A bacterial cell culture comprising a bacterial host cell comprising:
Dependencies are inferred from the claim text.